Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models-Reference-Cited by-同舟云学术

Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models

Published:2024-03 Issue: Volume:367 Page:821-836
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Ansari Aysha S.,K.C. Remant,Morales Luis C.,Nasrullah Mohammad,Meenakshi Sundaram Daniel Nisakar,Kucharski Cezary,Jiang Xiaoyan,Brandwein Joseph,Uludağ Hasan

Funder

Canadian Institutes of Health Research

Alex's Lemonade Stand Foundation for Childhood Cancer

Publisher

Elsevier BV

Reference61 articles.

1. The treatment of CML at an environment with limited resources;Gómez-Almaguer;Hematology,2016

2. Advances in the treatment of acute myeloid leukemia: new drugs and new challenges;Short;Cancer Discov.,2020

3. Diagnosis and treatment of chronic lymphocytic leukemia: recommendations of the French CLL study group (FILO);Quinquenel;Hemasphere,2020

4. Recent advances in the treatment of acute lymphoblastic leukemia;Rafei;Leuk. Lymphoma,2019

5. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype;Melo;Blood,1996

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipopolymer/siRNA Complexes Engineered for Optimal Molecular and Functional Response with Chemotherapy in FLT3-Mutated Acute Myeloid Leukemia;Acta Biomaterialia;2024-09

2. Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia;ACS Pharmacology & Translational Science;2024-08-15